Felicitas S.
- Country
- Germany
- Department
- Klinik für Innere Medizin 3 (Hämatologie, Onkologie, Palliativmedizin)
Research Overview
- Efficacy and Safety of REGN7508 for Primary Prophylaxis of Cancer-Associated Thrombosis in Patients with Solid Tumors Undergoing Cancer Treatment
- Phase III Randomized, Placebo-Controlled Study of Venetoclax with Induction and Consolidation Chemotherapy in Newly Diagnosed AML or MDS-EB2 Patients
- Phase III Trial of Perioperative FLOT with HIPEC Versus FLOT Alone in Resectable Diffuse Gastric and Gastroesophageal Junction Adenocarcinoma
Data & Insights
Has run more than one trial at 10 of 170 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in treating acute myeloid leukemia (AML), with particular emphasis on developing innovative therapeutic approaches for patients who cannot undergo intensive chemotherapy treatments.
- NPM1-mutated AML management
- Novel combination therapies
- Treatment strategies for chemotherapy-ineligible patients
The research focus includes investigating targeted therapeutic combinations for specific genetic mutations in AML cases.
Precision Medicine
The investigator concentrates on developing personalized treatment approaches based on specific genetic abnormalities in blood cancers, particularly focusing on mutation-specific therapeutic strategies.
- Genetic mutation analysis
- Targeted therapy development
- Biomarker-driven treatment
Their work emphasizes the importance of molecular profiling in determining optimal treatment pathways.
Treatment Innovation
The investigator explores novel therapeutic combinations, including the integration of targeted agents with established treatments to improve patient survival outcomes.
- Combination therapy optimization
- Alternative treatment pathways
- Survival outcome improvement
Their research aims to advance treatment options for patients who require alternatives to standard intensive chemotherapy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.